Sign up
Log in
Top 3 Health Care Stocks That Are Set To Fly This Quarter
Share
Listen to the news

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.

Here's the latest list of major oversold players in this sector, having an RSI near or below 30.

BIMI Holdings Inc (NASDAQ:BIMI)

  • On May 20, BIMI announced the receipt of a delinquency compliance alert notice from Nasdaq.  The company's stock fell around 68% over the past five days and has a 52-week low of $0.24.
  • RSI Value: 24.62
  • BIMI Price Action: Shares of BIMI Holdings closed at $0.42 on Wednesday.
  • Benzinga Pro’s charting tool helped identify the trend in DXCM stock.

Edwards Lifesciences Corp (NYSE:EW

  • On July 24, Edwards Lifesciences reported worse-than-expected second-quarter sales results and issued third-quarter guidance below estimates. Also, the company acquired JenaValve and Endotronix.. The company's stock fell around 30% over the past month. It <a href=”https://www.benzinga.com/quote/EW”><em> has a 52-week low </em></a> of $58.93.
  • RSI Value: 22.55
  • EW Price Action: Shares of Edwards Lifesciences closed at $63.05 on Wednesday.
  • Benzinga Pro’s real-time newsfeed alerted to latest EW news.

Merck & Co Inc (NYSE:MRK)

  • Merck reported better-than-expected second-quarter earnings and sales results on Tuesday. The company posted quarterly sales of $16.1 billion, up 7% year-over-year, beating the consensus estimate of $15.84 billion. Excluding the impact of foreign exchange, sales increased 11%. Merck reported adjusted EPS of $2.28, a shift from an EPS loss of $(2.06), beating the consensus of $2.15. The company's shares fell around 12% over the past month and has a 52-week <a href=”https://www.benzinga.com/quote/MRK”><em> low of $99.14.</em></a>
  • RSI Value: 28.20
  • MRK Price Action: Shares of Merck rose 0.1% to close at $113.13 on Wednesday.

Read More:

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.